International Business News - MLNM http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif With research and development pipelines lagging and patent expirations on many key drugs looming, large pharmaceutical and biotech companies are increasingly looking to biotechnology acquisitions as a way to bring new drugs forward. http://www.ibtimes.com/articles/20080612/market-spotlight-biotech-acquisition-trends.htm Thu, 12 Jun 2008 11:22:40 EDT Celgene Corp. said late Sunday that a mid-stage study showed that 29 percent of patients with a certain type of blood cancer responded to its drug Revlimid. The data was presented at the American Society of Clinical Oncology meeting in Chicago. http://www.ibtimes.com/articles/20080602/celgenes-revlimid-shows-results-for-blood-cancer.htm Mon, 02 Jun 2008 08:10:37 EDT With cancer drugs making up the bulk of sales for many biotech companies, Wall Street is gearing up for one of the year's most anticipated medical conferences, the American Society of Clinical Oncology's annual meeting starting Friday in Chicago. http://www.ibtimes.com/articles/20080528/market-spotlight-cancer-drug-conference.htm Wed, 28 May 2008 17:07:33 EDT